Logo image of BACK

IMAC HOLDINGS INC (BACK) Stock Fundamental Analysis

NASDAQ:BACK - Nasdaq - US44967K3023 - Common Stock - Currency: USD

0.656  -0.04 (-6.15%)

After market: 0.69 +0.03 (+5.18%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to BACK. BACK was compared to 108 industry peers in the Health Care Providers & Services industry. BACK may be in some trouble as it scores bad on both profitability and health. BACK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BACK has reported negative net income.
In the past year BACK has reported a negative cash flow from operations.
In the past 5 years BACK always reported negative net income.
BACK had a negative operating cash flow in each of the past 5 years.
BACK Yearly Net Income VS EBIT VS OCF VS FCFBACK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

The Return On Assets of BACK (-993.10%) is worse than 99.07% of its industry peers.
Industry RankSector Rank
ROA -993.1%
ROE N/A
ROIC N/A
ROA(3y)-342.39%
ROA(5y)-217.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BACK Yearly ROA, ROE, ROICBACK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K

1.3 Margins

BACK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BACK Yearly Profit, Operating, Gross MarginsBACK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

More info and screens

0

2. Health

2.1 Basic Checks

BACK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BACK has been increased compared to 1 year ago.
The number of shares outstanding for BACK has been increased compared to 5 years ago.
BACK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BACK Yearly Shares OutstandingBACK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M
BACK Yearly Total Debt VS Total AssetsBACK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -76.87, we must say that BACK is in the distress zone and has some risk of bankruptcy.
BACK has a worse Altman-Z score (-76.87) than 94.39% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -76.87
ROIC/WACCN/A
WACC8.17%
BACK Yearly LT Debt VS Equity VS FCFBACK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M 15M

2.3 Liquidity

A Current Ratio of 0.08 indicates that BACK may have some problems paying its short term obligations.
BACK's Current ratio of 0.08 is on the low side compared to the rest of the industry. BACK is outperformed by 95.33% of its industry peers.
BACK has a Quick Ratio of 0.08. This is a bad value and indicates that BACK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BACK (0.08) is worse than 95.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
BACK Yearly Current Assets VS Current LiabilitesBACK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

BACK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.07%, which is quite impressive.
Looking at the last year, BACK shows a very negative growth in Revenue. The Revenue has decreased by -99.15% in the last year.
EPS 1Y (TTM)66.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.53%
Revenue 1Y (TTM)-99.15%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-96.42%

3.2 Future

Based on estimates for the next years, BACK will show a very strong growth in Earnings Per Share. The EPS will grow by 25.68% on average per year.
BACK is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -41.42% yearly.
EPS Next Y69.42%
EPS Next 2Y25.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BACK Yearly Revenue VS EstimatesBACK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
BACK Yearly EPS VS EstimatesBACK Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BACK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BACK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BACK Price Earnings VS Forward Price EarningsBACK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BACK Per share dataBACK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

BACK's earnings are expected to grow with 25.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.68%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BACK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IMAC HOLDINGS INC

NASDAQ:BACK (2/21/2025, 8:02:37 PM)

After market: 0.69 +0.03 (+5.18%)

0.656

-0.04 (-6.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)01-17 2025-01-17/amc
Earnings (Next)04-14 2025-04-14
Inst Owners1.61%
Inst Owner Change-8.03%
Ins Owners3.33%
Ins Owner Change46.44%
Market Cap1.36M
Analysts82.86
Price Target8.41 (1182.01%)
Short Float %20.47%
Short Ratio0.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-169.38%
Min EPS beat(2)-283.24%
Max EPS beat(2)-55.51%
EPS beat(4)1
Avg EPS beat(4)-88.1%
Min EPS beat(4)-283.24%
Max EPS beat(4)62.29%
EPS beat(8)1
Avg EPS beat(8)-131.33%
EPS beat(12)2
Avg EPS beat(12)-105.9%
EPS beat(16)5
Avg EPS beat(16)-68.76%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 18.85
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.76
EYN/A
EPS(NY)-3.55
Fwd EYN/A
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)-0.9
OCFYN/A
SpS0.03
BVpS-2.32
TBVpS-2.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -993.1%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-342.39%
ROA(5y)-217.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -76.87
F-Score2
WACC8.17%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.53%
EPS Next Y69.42%
EPS Next 2Y25.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-99.15%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-96.42%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y82.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.55%
OCF growth 3YN/A
OCF growth 5YN/A